Category: Product reviews
| Posted on Sun, November, 8th 2015 by THCFinder
There are new products being invented and introduced to the marijuana industry on a daily basis. A lot of those inventions are just spins on old ones, usually involving vape pens, extraction equipment, and grow equipment. A lot of those inventions are not well received with consumers because there are so many similar products out there. But every once in awhile there are inventions that raise eyebrows. One of those, for me, came this week when I heard about a cannabis inhaler.
I have heard of people working on cannabis inhaler inventions for awhile, but this is the first one I have heard of that is ready for the market (feel free to mention others in the comments if they exist).Yahoo Finance reported this week that a Canadian company called Aurora Cannabis Inc. has filed for the rights to distribute an inhaler called Mystabis. Per the article:
Aurora Cannabis Inc. (“Aurora” or the “Company”) (CSE:ACB)(ACBFF)(21P.F)(WKN:A1C4WM) is pleased to announce that it has entered into a letter of intent (“LOI”) for exclusive distribution rights to Mystabis, a revolutionary inhaler that provides pressurized metered doses of cannabis.
The terms of the arrangement allow Aurora sole Canadian distribution of the device. The ability to administer metered doses is something that both patients and the medical community have been waiting for eagerly. Without the use of any form of heat or combustion, this pressurized inhaler (“pMDI”) delivers exact quantities of cannabinoids in a manner that provides rapid medicinal effects while preserving the entourage effects of the cannabinoids and terpenoids. Physicians will find the delivery mechanism to be very familiar and will appreciate the precision controlled per dose delivery of both the THC and CBD dominant formulations.